0.018408
0.010628
0.000000
0.000000
0.021256
0.000000
0.000000
0.000000
0.009495
0.00000
0.00000
0.00000
Newman, J.
Peat, T.S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
6
90.00
90.00
120.00
54.323
54.323
105.320
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
Ca 2
40.078
CALCIUM ION
non-polymer
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H6 O2
62.068
1,2-ETHANEDIOL
ETHYLENE GLYCOL
non-polymer
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
O4 S -2
96.063
SULFATE ION
non-polymer
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
C10 H13 N O2
179.216
3,4-dihydro-2H-1,5-benzodioxepin-6-ylmethanamine
CC00413
non-polymer
N
1
N
N
N
2
S
C
N
3
N
C
N
4
N
O
N
5
N
C
N
6
N
O
N
7
N
H
N
8
N
H
N
9
N
H
N
10
N
H
N
11
N
H
N
12
N
H
N
13
N
H
N
14
N
N
N
15
S
C
N
16
N
C
N
17
N
O
N
18
N
C
N
19
N
C
N
20
N
C
N
21
N
N
N
22
N
C
N
23
N
N
N
24
N
N
N
25
N
O
N
26
N
H
N
27
N
H
N
28
N
H
N
29
N
H
N
30
N
H
N
31
N
H
N
32
N
H
N
33
N
H
N
34
N
H
N
35
N
H
N
36
N
H
N
37
N
H
N
38
N
H
N
39
N
H
N
40
N
H
N
41
N
N
N
42
S
C
N
43
N
C
N
44
N
O
N
45
N
C
N
46
N
C
N
47
N
O
N
48
N
N
N
49
N
O
N
50
N
H
N
51
N
H
N
52
N
H
N
53
N
H
N
54
N
H
N
55
N
H
N
56
N
H
N
57
N
H
N
58
N
N
N
59
S
C
N
60
N
C
N
61
N
O
N
62
N
C
N
63
N
C
N
64
N
O
N
65
N
O
N
66
N
O
N
67
N
H
N
68
N
H
N
69
N
H
N
70
N
H
N
71
N
H
N
72
N
H
N
73
N
H
N
74
N
CA
N
75
N
N
N
76
R
C
N
77
N
C
N
78
N
O
N
79
N
C
N
80
N
S
N
81
N
O
N
82
N
H
N
83
N
H
N
84
N
H
N
85
N
H
N
86
N
H
N
87
N
H
N
88
N
H
N
89
N
C
N
90
N
O
N
91
N
C
N
92
N
O
N
93
N
H
N
94
N
H
N
95
N
H
N
96
N
H
N
97
N
H
N
98
N
H
N
99
N
N
N
100
S
C
N
101
N
C
N
102
N
O
N
103
N
C
N
104
N
C
N
105
N
C
N
106
N
O
N
107
N
N
N
108
N
O
N
109
N
H
N
110
N
H
N
111
N
H
N
112
N
H
N
113
N
H
N
114
N
H
N
115
N
H
N
116
N
H
N
117
N
H
N
118
N
H
N
119
N
N
N
120
S
C
N
121
N
C
N
122
N
O
N
123
N
C
N
124
N
C
N
125
N
C
N
126
N
O
N
127
N
O
N
128
N
O
N
129
N
H
N
130
N
H
N
131
N
H
N
132
N
H
N
133
N
H
N
134
N
H
N
135
N
H
N
136
N
H
N
137
N
H
N
138
N
N
N
139
N
C
N
140
N
C
N
141
N
O
N
142
N
O
N
143
N
H
N
144
N
H
N
145
N
H
N
146
N
H
N
147
N
H
N
148
N
N
N
149
S
C
N
150
N
C
N
151
N
O
N
152
N
C
Y
153
N
C
Y
154
N
N
Y
155
N
C
Y
156
N
C
Y
157
N
N
N
158
N
O
N
159
N
H
N
160
N
H
N
161
N
H
N
162
N
H
N
163
N
H
N
164
N
H
N
165
N
H
N
166
N
H
N
167
N
H
N
168
N
H
N
169
N
O
N
170
N
H
N
171
N
H
N
172
N
N
N
173
S
C
N
174
N
C
N
175
N
O
N
176
S
C
N
177
N
C
N
178
N
C
N
179
N
C
N
180
N
O
N
181
N
H
N
182
N
H
N
183
N
H
N
184
N
H
N
185
N
H
N
186
N
H
N
187
N
H
N
188
N
H
N
189
N
H
N
190
N
H
N
191
N
H
N
192
N
H
N
193
N
H
N
194
N
N
N
195
S
C
N
196
N
C
N
197
N
O
N
198
N
C
N
199
N
C
N
200
N
C
N
201
N
C
N
202
N
O
N
203
N
H
N
204
N
H
N
205
N
H
N
206
N
H
N
207
N
H
N
208
N
H
N
209
N
H
N
210
N
H
N
211
N
H
N
212
N
H
N
213
N
H
N
214
N
H
N
215
N
H
N
216
N
N
N
217
S
C
N
218
N
C
N
219
N
O
N
220
N
C
N
221
N
C
N
222
N
C
N
223
N
C
N
224
N
N
N
225
N
O
N
226
N
H
N
227
N
H
N
228
N
H
N
229
N
H
N
230
N
H
N
231
N
H
N
232
N
H
N
233
N
H
N
234
N
H
N
235
N
H
N
236
N
H
N
237
N
H
N
238
N
H
N
239
N
H
N
240
N
H
N
241
N
N
N
242
S
C
N
243
N
C
N
244
N
O
N
245
N
C
N
246
N
C
N
247
N
S
N
248
N
C
N
249
N
O
N
250
N
H
N
251
N
H
N
252
N
H
N
253
N
H
N
254
N
H
N
255
N
H
N
256
N
H
N
257
N
H
N
258
N
H
N
259
N
H
N
260
N
H
N
261
N
N
N
262
S
C
N
263
N
C
N
264
N
O
N
265
N
C
Y
266
N
C
Y
267
N
C
Y
268
N
C
Y
269
N
C
Y
270
N
C
Y
271
N
C
N
272
N
O
N
273
N
H
N
274
N
H
N
275
N
H
N
276
N
H
N
277
N
H
N
278
N
H
N
279
N
H
N
280
N
H
N
281
N
H
N
282
N
H
N
283
N
H
N
284
N
N
N
285
S
C
N
286
N
C
N
287
N
O
N
288
N
C
N
289
N
C
N
290
N
C
N
291
N
O
N
292
N
H
N
293
N
H
N
294
N
H
N
295
N
H
N
296
N
H
N
297
N
H
N
298
N
H
N
299
N
H
N
300
N
H
N
301
N
N
N
302
S
C
N
303
N
C
N
304
N
O
N
305
N
C
N
306
N
O
N
307
N
O
N
308
N
H
N
309
N
H
N
310
N
H
N
311
N
H
N
312
N
H
N
313
N
H
N
314
N
H
N
315
N
S
N
316
N
O
N
317
N
O
N
318
N
O
N
319
N
O
N
320
N
N
N
321
S
C
N
322
N
C
N
323
N
O
N
324
R
C
N
325
N
O
N
326
N
C
N
327
N
O
N
328
N
H
N
329
N
H
N
330
N
H
N
331
N
H
N
332
N
H
N
333
N
H
N
334
N
H
N
335
N
H
N
336
N
H
N
337
N
N
N
338
S
C
N
339
N
C
N
340
N
O
N
341
N
C
Y
342
N
C
Y
343
N
C
Y
344
N
C
Y
345
N
N
Y
346
N
C
Y
347
N
C
Y
348
N
C
Y
349
N
C
Y
350
N
C
N
351
N
O
N
352
N
H
N
353
N
H
N
354
N
H
N
355
N
H
N
356
N
H
N
357
N
H
N
358
N
H
N
359
N
H
N
360
N
H
N
361
N
H
N
362
N
H
N
363
N
H
N
364
N
N
N
365
S
C
N
366
N
C
N
367
N
O
N
368
N
C
Y
369
N
C
Y
370
N
C
Y
371
N
C
Y
372
N
C
Y
373
N
C
Y
374
N
C
N
375
N
O
N
376
N
O
N
377
N
H
N
378
N
H
N
379
N
H
N
380
N
H
N
381
N
H
N
382
N
H
N
383
N
H
N
384
N
H
N
385
N
H
N
386
N
H
N
387
N
H
N
388
N
N
N
389
S
C
N
390
N
C
N
391
N
O
N
392
N
C
N
393
N
C
N
394
N
C
N
395
N
O
N
396
N
H
N
397
N
H
N
398
N
H
N
399
N
H
N
400
N
H
N
401
N
H
N
402
N
H
N
403
N
H
N
404
N
H
N
405
N
H
N
406
N
H
Y
407
N
C
Y
408
N
C
Y
409
N
C
Y
410
N
C
Y
411
N
C
Y
412
N
C
N
413
N
C
N
414
N
C
N
415
N
C
N
416
N
C
N
417
N
N
N
418
N
O
N
419
N
O
N
420
N
H
N
421
N
H
N
422
N
H
N
423
N
H
N
424
N
H
N
425
N
H
N
426
N
H
N
427
N
H
N
428
N
H
N
429
N
H
N
430
N
H
N
431
N
H
N
432
N
H
N
1
N
sing
N
2
N
sing
N
3
N
sing
N
4
N
sing
N
5
N
sing
N
6
N
sing
N
7
N
doub
N
8
N
sing
N
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
sing
N
13
N
sing
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
doub
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
sing
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
doub
N
34
N
sing
N
35
N
sing
N
36
N
sing
N
37
N
sing
N
38
N
sing
N
39
N
sing
N
40
N
sing
N
41
N
sing
N
42
N
sing
N
43
N
sing
N
44
N
sing
N
45
N
doub
N
46
N
sing
N
47
N
sing
N
48
N
sing
N
49
N
sing
N
50
N
doub
N
51
N
sing
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
sing
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
doub
N
62
N
sing
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
doub
N
67
N
sing
N
68
N
sing
N
69
N
sing
N
70
N
sing
N
71
N
sing
N
72
N
sing
N
73
N
sing
N
74
N
sing
N
75
N
sing
N
76
N
doub
N
77
N
sing
N
78
N
sing
N
79
N
sing
N
80
N
sing
N
81
N
sing
N
82
N
sing
N
83
N
sing
N
84
N
sing
N
85
N
sing
N
86
N
sing
N
87
N
sing
N
88
N
sing
N
89
N
sing
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
sing
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
sing
N
98
N
doub
N
99
N
sing
N
100
N
sing
N
101
N
sing
N
102
N
sing
N
103
N
sing
N
104
N
sing
N
105
N
sing
N
106
N
doub
N
107
N
sing
N
108
N
sing
N
109
N
sing
N
110
N
sing
N
111
N
sing
N
112
N
sing
N
113
N
sing
N
114
N
sing
N
115
N
sing
N
116
N
sing
N
117
N
doub
N
118
N
sing
N
119
N
sing
N
120
N
sing
N
121
N
sing
N
122
N
sing
N
123
N
sing
N
124
N
sing
N
125
N
doub
N
126
N
sing
N
127
N
sing
N
128
N
sing
N
129
N
sing
N
130
N
sing
N
131
N
sing
N
132
N
sing
N
133
N
sing
N
134
N
sing
N
135
N
doub
N
136
N
sing
N
137
N
sing
N
138
N
sing
N
139
N
sing
N
140
N
sing
N
141
N
sing
N
142
N
sing
N
143
N
sing
N
144
N
doub
N
145
N
sing
N
146
N
sing
N
147
N
sing
N
148
N
sing
Y
149
N
sing
Y
150
N
doub
Y
151
N
doub
N
152
N
sing
Y
153
N
sing
N
154
N
sing
Y
155
N
sing
N
156
N
sing
N
157
N
sing
N
158
N
sing
N
159
N
sing
N
160
N
sing
N
161
N
sing
N
162
N
sing
N
163
N
sing
N
164
N
sing
N
165
N
sing
N
166
N
sing
N
167
N
doub
N
168
N
sing
N
169
N
sing
N
170
N
sing
N
171
N
sing
N
172
N
sing
N
173
N
sing
N
174
N
sing
N
175
N
sing
N
176
N
sing
N
177
N
sing
N
178
N
sing
N
179
N
sing
N
180
N
sing
N
181
N
sing
N
182
N
sing
N
183
N
sing
N
184
N
sing
N
185
N
sing
N
186
N
sing
N
187
N
sing
N
188
N
doub
N
189
N
sing
N
190
N
sing
N
191
N
sing
N
192
N
sing
N
193
N
sing
N
194
N
sing
N
195
N
sing
N
196
N
sing
N
197
N
sing
N
198
N
sing
N
199
N
sing
N
200
N
sing
N
201
N
sing
N
202
N
sing
N
203
N
sing
N
204
N
sing
N
205
N
sing
N
206
N
sing
N
207
N
sing
N
208
N
sing
N
209
N
doub
N
210
N
sing
N
211
N
sing
N
212
N
sing
N
213
N
sing
N
214
N
sing
N
215
N
sing
N
216
N
sing
N
217
N
sing
N
218
N
sing
N
219
N
sing
N
220
N
sing
N
221
N
sing
N
222
N
sing
N
223
N
sing
N
224
N
sing
N
225
N
sing
N
226
N
sing
N
227
N
sing
N
228
N
sing
N
229
N
sing
N
230
N
sing
N
231
N
sing
N
232
N
sing
N
233
N
doub
N
234
N
sing
N
235
N
sing
N
236
N
sing
N
237
N
sing
N
238
N
sing
N
239
N
sing
N
240
N
sing
N
241
N
sing
N
242
N
sing
N
243
N
sing
N
244
N
sing
N
245
N
sing
N
246
N
sing
N
247
N
sing
N
248
N
sing
N
249
N
sing
N
250
N
sing
N
251
N
sing
N
252
N
doub
N
253
N
sing
N
254
N
sing
N
255
N
sing
N
256
N
sing
Y
257
N
doub
Y
258
N
sing
Y
259
N
sing
N
260
N
sing
Y
261
N
doub
N
262
N
sing
Y
263
N
doub
N
264
N
sing
Y
265
N
sing
N
266
N
sing
N
267
N
sing
N
268
N
sing
N
269
N
sing
N
270
N
sing
N
271
N
sing
N
272
N
sing
N
273
N
sing
N
274
N
sing
N
275
N
doub
N
276
N
sing
N
277
N
sing
N
278
N
sing
N
279
N
sing
N
280
N
sing
N
281
N
sing
N
282
N
sing
N
283
N
sing
N
284
N
sing
N
285
N
sing
N
286
N
sing
N
287
N
sing
N
288
N
sing
N
289
N
sing
N
290
N
sing
N
291
N
sing
N
292
N
doub
N
293
N
sing
N
294
N
sing
N
295
N
sing
N
296
N
sing
N
297
N
sing
N
298
N
sing
N
299
N
doub
N
300
N
doub
N
301
N
sing
N
302
N
sing
N
303
N
sing
N
304
N
sing
N
305
N
sing
N
306
N
sing
N
307
N
sing
N
308
N
sing
N
309
N
doub
N
310
N
sing
N
311
N
sing
N
312
N
sing
N
313
N
sing
N
314
N
sing
N
315
N
sing
N
316
N
sing
N
317
N
sing
N
318
N
sing
N
319
N
sing
N
320
N
sing
N
321
N
sing
N
322
N
sing
N
323
N
sing
N
324
N
sing
N
325
N
doub
N
326
N
sing
N
327
N
sing
N
328
N
sing
N
329
N
sing
Y
330
N
doub
Y
331
N
sing
Y
332
N
sing
N
333
N
sing
Y
334
N
doub
Y
335
N
sing
Y
336
N
sing
N
337
N
sing
Y
338
N
sing
Y
339
N
doub
N
340
N
sing
Y
341
N
doub
N
342
N
sing
Y
343
N
sing
N
344
N
sing
N
345
N
sing
N
346
N
sing
N
347
N
sing
N
348
N
sing
N
349
N
sing
N
350
N
sing
N
351
N
sing
N
352
N
sing
N
353
N
doub
N
354
N
sing
N
355
N
sing
N
356
N
sing
N
357
N
sing
Y
358
N
doub
Y
359
N
sing
Y
360
N
sing
N
361
N
sing
Y
362
N
doub
N
363
N
sing
Y
364
N
doub
N
365
N
sing
Y
366
N
sing
N
367
N
sing
N
368
N
sing
N
369
N
sing
N
370
N
sing
N
371
N
sing
N
372
N
sing
N
373
N
sing
N
374
N
sing
N
375
N
sing
N
376
N
sing
N
377
N
doub
N
378
N
sing
N
379
N
sing
N
380
N
sing
N
381
N
sing
N
382
N
sing
N
383
N
sing
N
384
N
sing
N
385
N
sing
N
386
N
sing
N
387
N
sing
N
388
N
sing
Y
389
N
sing
Y
390
N
doub
Y
391
N
doub
Y
392
N
sing
Y
393
N
sing
N
394
N
sing
Y
395
N
doub
N
396
N
sing
N
397
N
sing
N
398
N
sing
N
399
N
sing
N
400
N
sing
N
401
N
sing
N
402
N
sing
N
403
N
sing
N
404
N
sing
N
405
N
sing
N
406
N
sing
N
407
N
sing
N
408
N
sing
N
409
N
sing
N
410
N
sing
N
411
N
sing
N
412
N
sing
N
413
N
sing
N
414
N
sing
N
415
N
sing
NE
J.Comput.Aided Mol.Des.
0920-654X
26
497
10.1007/S10822-011-9521-2
22187139
The Dingo Dataset: A Comprehensive Set of Data for the Sampl Challenge.
2012
US
J.Biomol.Screen
1087-0571
14
1245
10.1177/1087057109348220
19822883
Practical Aspects of the Sampl Challenge: Providing an Extensive Experimental Data Set for the Modeling Community.
2009
AT
Aust.J.Chem.
AJCHAS
0154
0004-9425
66
1507
10.1071/CH13302
Fragment Screening for the Modelling Community: Spr, Itc, and Crystallography
2013
10.2210/pdb4ab8/pdb
pdb_00004ab8
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
CCD
2011-10-25
ADSC QUANTUM 210r
SINGLE WAVELENGTH
M
x-ray
1
0.95369
1.0
MX1
Australian Synchrotron
0.95369
SYNCHROTRON
AUSTRALIAN SYNCHROTRON BEAMLINE MX1
23324.287
CATIONIC TRYPSIN
3.4.21.4
1
nat
polymer
96.063
SULFATE ION
1
syn
non-polymer
40.078
CALCIUM ION
1
syn
non-polymer
62.068
1,2-ETHANEDIOL
5
syn
non-polymer
179.216
3,4-dihydro-2H-1,5-benzodioxepin-6-ylmethanamine
1
syn
non-polymer
18.015
water
158
nat
water
BETA-TRYPSIN, ALPHA-TRYPSIN CHAIN 1, ALPHA-TRYPSIN CHAIN 2
no
no
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNT
LNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNM
FCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNT
LNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNM
FCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
CATTLE
SIGMA
sample
9913
PANCREAS
BOS TAURUS
1000
1.92
36.1
NONE
5.8
22.5% PEG 3350, 0.18 M AMMONIUM SULFATE, 0.12 M SODIUM THIOCYANATE, 0.09 M BIS-TRIS PH 5.5, 0.01 M TRIS PH 8.5 (FINAL MEASURED PH=5.82). THE PROTEIN WAS AT 2 MM (47 MG/ML), WITH 4 MM BENZYLAMINE AND 10 MM CALCIUM CHLORIDE ADDED TO STABILIZE IT. THE CRYSTALLIZATIONS WERE SET UP WITH A PHOENITO PROTOCOL (NEWMAN ET AL. 2008), WHERE A PHOENIX ROBOT (ART ROBBINS INSTRUMENTS, SUNNYSIDE, CA) WAS USED TO DISPENSE THE PROTEIN INTO AN SD2 CRYSTALLIZATION PLATE (PRE-FILLED WITH 50 ML RESERVOIR SOLUTION) AND A MOSQUITO ROBOT (TTP LABTECH, MELBOURN, UK) WAS USED TO DISPENSE THE RESERVOIR SOLUTION AND SEED STOCK OVER THE PROTEIN DROPLET.
chem_comp_atom
chem_comp_bond
citation
database_2
pdbx_database_status
pdbx_initial_refinement_model
pdbx_validate_polymer_linkage
struct_site
repository
Initial release
Database references
Advisory
Data collection
Database references
Derived calculations
Other
Refinement description
1
0
2012-02-08
1
1
2014-02-05
1
2
2023-12-20
_citation.country
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_sf
_pdbx_validate_polymer_linkage.dist
_pdbx_validate_polymer_linkage.label_alt_id_2
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
STRUCTURE OF HYDROLASE (SERINE PROTEINASE)
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
BETA-TRYPSIN COMPLEXED WITH APPU
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
TRYPSIN COMPLEXED WITH INHIBITOR A90720A
TRYPSIN COMPLEXED WITH THE INHIBITOR AMINOMETHYLCYCLOHEXANE
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN
BOVINE TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR ( CUCURBITA PEPO TRYPSIN INHIBITOR II)
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
TRYPSIN COMPLEXED WITH THE INHIBITOR 3-PHENYLPROPYLAMINE
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
CRYSTAL STRUCTURE OF CANCER CHEMOPREVENTIVE BOWMAN-BIRK INHIBITOR IN TERNARY COMPLEX WITH BOVINE TRYPSIN AT 2 .3 A RESOLUTION. STRUCTURAL BASIS OF JANUS-FACED SERINE PROTEASE INHIBITOR SPECIFICITY
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X -RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA- TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY AT 1.8 A RESOLUTION
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
HIGH PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE
FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSINVARIANT X(TRIPLE.GLU)BT.D2
BETA-TRYPSIN (ORTHORHOMBIC) AT PH5.0
TRYPSIN AFTER A HIGH DOSE X-RAY "BURN"
TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSYI)BT.B4
BOVINE TRYPSIN COMPLEXED WITH 2-AMINOBENZAMIDAZOLE
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
TRYPSIN INHIBITOR COMPLEX
TRYPSIN INHIBITOR COMPLEX
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
RIP-PHASING ON BOVINE TRYPSIN
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
BOVINE TRYPSIN-INHIBITOR COMPLEX
BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X( SSAI)BT.C1
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFICINHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT
CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS14->SER, CYS38 ->SER) IN COMPLEX WITH TRYPSIN
BOVINE TRYPSIN WITH 1-[2-[5-[AMINO(IMINO)METHYL]-2 - HYDROXYPHENOXY]-6-[3-(4,5-DIHYDRO-1-METHYL-1H- IMIDAZOL-2-YL) PHENOXY]PYRIDIN-4-YL]PIPERIDINE-3- CARBOXYLIC ACID (ZK- 806974)
BETA-TRYPSIN COMPLEX WITH PANCREATIC TRYPSIN INHIBITOR
BOVINE TRYPSIN-INHIBITOR COMPLEX
TRYPSINOGEN, DIISOPROPYLPHOSPHORYL INHIBITED
DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFICINHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINETRYPSIN AND CHYMOTRYPSIN
TRYPSIN COMPLEXED WITH BOWMAN-BIRK INHIBITOR
MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: NULL; EC: 3 .4.21.4; HETEROGEN: N-[3-[4-[4-(AMIDINOPHENOXY)- CARBONYL]PHENYL]-2- METHYL-2-PROPENOYL]-N-ALLYLGLYCINE METHANESULFONATE
TRYPSIN COMPLEX WITH (CUCURBITA MAXIMA) TRYPSIN INHIBITOR (CMTI-I)
CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN TRYPSIN ANDA DESIGNED SYNTHETIC HIGHLY POTENT INHIBITOR IN THEPRESENCE OF BENZAMIDINE AT 0.97 A RESOLUTION
MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: A; EC: 3.4 .21.4; MOL_ID: 2; MOLECULE: T-BUTOXY-ALA-VAL-BORO- LYS ETHYL ESTER; CHAIN: H
IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
BOVINE TRYPSIN COMPLEXED WITH 2,6-BIS[3-AMINO(IMINO )METHYL PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK- 805623), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS
MODIFIED BETA TRYPSIN (MONOISOPROPYLPHOSPHORYL INHIBITED) ( NEUTRON DATA)
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
BOVINE TRYPSIN 7-[[2-[[1-(1-IMINOETHYL)PIPERIDIN-4- YL]OXY]- 9H-CARBOZOL-9-YL] METHYL]NAPHTHALENE-2- CARBOXIMIDAMIDE (ZK- 806450) COMPLEX
BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF- BASECOPPER (II) CHELATE
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI
CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN
TRYPSIN (TRIGONAL, 2.4 M AMMONIUM SULFATE)
TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X -RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS14->SER) IN COMPLEXWITH TRYPSIN
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN INHIBITOR COMPLEX
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN COMPLEX WITH NONCOVALENTLY BOUND NAPAP
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
CRYSTAL STRUCTURE OF BENZAMIDINE INHIBITED BOVINEPANCREATIC TRYPSIN AT 105K TO 1.21A RESOLUTION FROMLABORATORY SOURCE WITH HIGH NUMBER OF WATERS MODELLED
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFICINHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT
TRYPSINOGEN (103 DEGREES K, 0.70 METHANOL, 0.30 WATER)
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI
BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSFI .GLU)BT.D1
TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI.
NATIVE BOVINE PANCREATIC TRYPSIN
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
BETA-TRYPSIN COMPLEXED WITH ACPU
BOVINE TRYPSIN 3,3'-[3,5-DIFLUORO-4-METHYL-2, 6- PYRIDINEDIYLBIS(OXY)]BIS(BENZENECARBOXIMIDAMIDE) (ZK-805623 ) COMPLEX
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN COMPLEX WITH BOWMAN-BIRK INHIBITOR (AB-I)
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASECOPPER (II) CHELATE
BOVINE TRYPSIN COMPLEXED WITH 2-[3-AMINO(IMINOMETHYL) PHENOXY]-6-[3-(AMINOMETHYL)PHENOXY]-3,5-DIFLUORO-4- METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS
ANHYDRO-TRYPSIN COMPLEX WITH PANCREATIC TRYPSIN INHIBITOR
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BPTI AT 100K
TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSRI)BT.B4
FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
BOVINE TRYPSIN COMPLEXED WITH AMSO
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI
BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X( SSRI)BT.C1
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
BOVINE TRYPSIN-INHIBITOR COMPLEX
TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X -RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE
IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
BOVINE TRYPSIN-INHIBITOR COMPLEX
TRYPSIN INHIBITOR COMPLEX
BETA-TRYPSIN PHOSPHONATE INHIBITED
TRYPSINOGEN (0.50 METHANOL, 0.50 WATER)
NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH ANDS195A TRYPSIN
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI.
POTENT FACTOR XA INHIBITOR IN COMPLEX WITH BOVINE TRYPSINVARIANT X(99/175/190)BT
TRYPSIN INHIBITOR COMPLEX (FRA)
LOW PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE
TRYPSINOGEN COMPLEX WITH PANCREATIC TRYPSIN INHIBITOR AND ILE-VAL
BOVINE TRYPSIN COMPLEX WITH A MODIFIED SSI (STREPTOMYCES SUBTILISIN INHIBITOR) WITH MET 70 REPLACED BY GLY AND MET 73 REPLACED BY LYS (SSI(M70G,M73K))
MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: NULL; EC: 3 .4.21.4; HETEROGEN: BENZAMIDINE
TRYPSIN (ORTHORHOMBIC, 2.4 M AMMONIUM SULFATE)
CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS38->SER) IN COMPLEXWITH TRYPSIN
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSFI.GLU)BT.B4
TRYPSINOGEN (2.4 M MAGNESIUM SULFATE)
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
CRYSTAL COMPLEX BETWEEN BOVINE TRYPSIN AND VERONICA HEDERIFOLIA TRYPSIN INHIBITOR
BOVINE TRYPSIN COMPLEXED WITH RPR128515
IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSINOGEN (173 DEGREES K, 0.70 METHANOL, 0.30 WATER)
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI
BOVINE TRYPSIN COMPLEXED TO BIS-PHENYLAMIDINE INHIBITOR
TRYPSINOGEN-CA FROM PEG
CRYSTAL STRUCTURE OF THE RWJ-51084 BOVINE PANCREATIC BETA- TRYPSIN AT 1.8 A
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINETRYPSIN AND CHYMOTRYPSIN
BOVINE TRYPSIN COMPLEXED WITH P- AMIDINOPHENYLMETHYLPHOSPHINIC ACID (AMPA)
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN WITH INHIBITOR AERUGINOSIN 98-B
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
BOVINE PANCREATIC TRYPSIN INHIBITED WITH BENZAMIDINE ATATOMIC RESOLUTION
CRYSTAL STRUCTURE OF MUNG BEAN INHIBITOR LYSINE ACTIVE FRAGMENT COMPLEX WITH BOVINE BETA-TRYPSIN AT 1.8A RESOLUTION
DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFICINHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT
TRYPSIN INHIBITOR COMPLEX
BOVINE TRYPSIN 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN-4- YL]OXY]- 2-METHYL-BENZIMIDAZOL-1-YL]METHYL]NAPHTHALENE -2- CARBOXIMIDAMID ZK-806711 INHIBITOR COMPLEX
MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: A; EC: 3.4 .21.4; MOL_ID: 2; MOLECULE: T-BUTOXY-ALA-VAL-BORO- LYS 1,3-PROPANEDIOL MONOESTER; CHAIN: H
TRYPSIN-KETO-BABIM-ZN+2, PH 8.2
TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSWI)BT.B4
TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X -RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
TRYPSINOGEN
BOVINE TRYPSIN-INHIBITOR COMPLEX
BOVINE TRYPSIN-INHIBITOR COMPLEX
BETA-TRYPSIN COMPLEX WITH P-AMIDINO-PHENYL-PYRUVATE ( APPA)
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ATOMIC RESOLUTION STRUCTURES OF TRYPSIN PROVIDE INSIGHT INTO STRUCTURAL RADIATION DAMAGE
CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE
COMPLEX OF BDELLASTASIN WITH BOVINE TRYPSIN
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
CRYSTAL STRUCTURE OF THE BOVINE TRYPSIN COMPLEX WITH ASYNTHETIC 11 PEPTIDE INHIBITOR
CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH THE BPTIVARIANT (TYR35->GLY)
BOVINE TRYPSIN IN COMPLEX WITH EVOLUTIONARY ENHANCED SCHISTOCERCA GREGARIA PROTEASE INHIBITOR 1 (SGPI-1-P02)
TRYPSIN BEFORE A HIGH DOSE X-RAY "BURN"
TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSAI)BT.B4
FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASEMAGNESIUM(II) CHELATE
BETA-TRYPSIN (ORTHORHOMBIC) AT PH 5.3
FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
BOVINE TRYPSIN 2-AMINOBENZIMIDAZOLE COMPLEX
CRYSTAL STRUCTURE OF TRYPSIN IN COMPLEX WITH 79.
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN COMPLEXED WITH THE INHIBITOR 4-FLUOROBENZYLAMINE
TRYPSIN-BABIM-ZN+2, PH 8.2
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
STRUCTURE OF TRYPSIN (ORTHORHOMBIC) WITH 1-(4-TERT- BUTYLCARBAMOYL- PIPERAZINE-1-CARBONYL)-3-(3-GUANIDINO- PROPYL)-4-OXO-AZETIDINE-2-CARBOXYLIC ACID
TRYPSIN COMPLEXED WITH THE INHIBITOR 4-PHENYLBUTYLAMINE
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: A; EC: 3.4 .21.4; MOL_ID: 2; MOLECULE: T-BUTOXY-ALA-VAL-BORO- LYS METHYL ESTER; CHAIN: H
TRYPSIN INHIBITOR COMPLEX
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI
BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANTX( TRIPLE.GLU)BT.A1
POTENT, SMALL MOLECULE INHIBITORS OF HUMAN MAST CELLTRYPTASE. ANTI-ASTHMATIC ACTION OF A DIPEPTIDE- BASEDTRANSITION STATE ANALOGUE CONTAINING BENZOTHIAZOLE KETONE
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN THE BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI.
BOVINE TRYPSIN COMPLEXED TO APPI
TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
TRYPSINOGEN COMPLEX WITH PANCREATIC TRYPSIN INHIBITOR
HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN
TRYPSIN COMPLEXED WITH THE INHIBITOR TRANYLCYPROMINE
BOVINE TRYPSIN BOUND BY 4-PIPERIDINEBUTYRATE TO MAKEACYLENZYME COMPLEX
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
BOVINE TRYPSIN COMPLEXED WITH RPR131247
RIP-PHASING ON BOVINE TRYPSIN
BOVINE TRYPSIN-INHIBITOR COMPLEX
CRYSTAL STRUCTURE OF KUNITZ DOMAIN 1 OF TISSUE FACTORPATHWAY INHIBITOR-2 WITH BOVINE TRYPSIN
CRYSTAL STRUCTURE OF TRYPSIN COMPLEX WITH AMYLAMINE INCYCLOHEXANE
BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARINAT X( SSAI)BT.D1
BETA-TRYPSIN PHOSPHONATE INHIBITED
IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
GUANIDINOBENZOYL-TRYPSIN ACYL-ENZYME AT 1.13 A RESOLUTION
TRYPSIN-BABIM-SULFATE, PH 5.9
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
STRUCTURE OF A TICK TRYPTASE INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
TRYPSINOGEN COMPLEX WITH PORCINE PANCREATIC SECRETORY TRYPSIN INHIBITOR
BETA TRYPSIN COMPLEXED WITH CYCLOTHEONAMIDE A
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSYI)BT.A4
ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULARCRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTIONWAVELENGTH
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSINOGEN - PANCREATIC TRYPSIN INHIBITOR - ILE-VAL COMPLEX (2.4 M MAGNESIUM SULFATE)
BOVINE TRYPSIN 2-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY ]-6- [3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENOXY] PYRIDINE-4- CARBOXYLIC ACID (ZK-806688) COMPLEX
IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANTX( TRIPLE.GLU)BT.D1
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSINOGEN COMPLEX WITH THE ARG==15==-ANALOGUE OF PANCREATIC TRYPSIN INHIBITOR AND VAL-VAL
HIGH RESOLUTION STRUCTURE OF A POTENT, CYCLIC PROTEASE INHIBITOR FROM SUNFLOWER SEEDS
STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINETRYPSIN AND CHYMOTRYPSIN
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZYLAMINE
TRYPSIN-KETO-BABIM-CO+2, PH 8.2
TRYPSIN INHIBITOR COMPLEX
BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF BASEIRON(III) CHELATE
BETA-TRYPSIN GUANIDINOBENZOYLATED AT SERINE 195 (PH 5. 5)
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI
TRYPSIN COMPLEX WITH NONCOVALENTLY BOUND 3-TAPAP
BOVINE TRYPSIN COMPLEXED WITH 2,6-BIS[3-AMINO(IMINO )METHYL PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK- 805623), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS
BETA-TRYPSIN (BENZAMIDINE INHIBITED) AT PH7
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
TRYPSIN-BABIM-ZN+2, PH 8.2
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
TRYPSIN COMPLEXED WITH THE INHIBITOR 2-PHENYLETHYLAMINE
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OFSERINE PROTEASES
TRYPSIN INHIBITOR COMPLEX
BOVINE TRYPSIN COMPLEXED TO META-CYANO-BENZYLIC INHIBITOR
ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
ROBOTICALLY HARVESTED TRYPSIN COMPLEXED WITH BENZAMIDINE CONTAINING POLYPEPTIDE MEDIATED CRYSTAL CONTACTS
FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
SHEET
DETERMINATION METHOD: DSSP
THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS
BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY
A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
ARE IDENTICAL.
PDBE
Y
PDBE
2011-12-08
REL
REL
1
A
O
HOH
2064
6.74
SO4
SULFATE ION
CA
CALCIUM ION
EDO
1,2-ETHANEDIOL
VXU
3,4-dihydro-2H-1,5-benzodioxepin-6-ylmethanamine
HOH
water
VXU: FRAGMENT CC00413 FROM MAYBRIDGE
1K1M
PDB ENTRY 1K1M
PDB
experimental model
SO4
1246
2
SO4
SO4
1246
A
CA
1247
3
CA
CA
1247
A
EDO
1248
4
EDO
EDO
1248
A
EDO
1249
4
EDO
EDO
1249
A
EDO
1250
4
EDO
EDO
1250
A
EDO
1251
4
EDO
EDO
1251
A
EDO
1252
4
EDO
EDO
1252
A
VXU
1253
5
VXU
VXU
1253
A
HOH
2001
6
HOH
HOH
2001
A
HOH
2002
6
HOH
HOH
2002
A
HOH
2003
6
HOH
HOH
2003
A
HOH
2004
6
HOH
HOH
2004
A
HOH
2005
6
HOH
HOH
2005
A
HOH
2006
6
HOH
HOH
2006
A
HOH
2007
6
HOH
HOH
2007
A
HOH
2008
6
HOH
HOH
2008
A
HOH
2009
6
HOH
HOH
2009
A
HOH
2010
6
HOH
HOH
2010
A
HOH
2011
6
HOH
HOH
2011
A
HOH
2012
6
HOH
HOH
2012
A
HOH
2013
6
HOH
HOH
2013
A
HOH
2014
6
HOH
HOH
2014
A
HOH
2015
6
HOH
HOH
2015
A
HOH
2016
6
HOH
HOH
2016
A
HOH
2017
6
HOH
HOH
2017
A
HOH
2018
6
HOH
HOH
2018
A
HOH
2019
6
HOH
HOH
2019
A
HOH
2020
6
HOH
HOH
2020
A
HOH
2021
6
HOH
HOH
2021
A
HOH
2022
6
HOH
HOH
2022
A
HOH
2023
6
HOH
HOH
2023
A
HOH
2024
6
HOH
HOH
2024
A
HOH
2025
6
HOH
HOH
2025
A
HOH
2026
6
HOH
HOH
2026
A
HOH
2027
6
HOH
HOH
2027
A
HOH
2028
6
HOH
HOH
2028
A
HOH
2029
6
HOH
HOH
2029
A
HOH
2030
6
HOH
HOH
2030
A
HOH
2031
6
HOH
HOH
2031
A
HOH
2032
6
HOH
HOH
2032
A
HOH
2033
6
HOH
HOH
2033
A
HOH
2034
6
HOH
HOH
2034
A
HOH
2035
6
HOH
HOH
2035
A
HOH
2036
6
HOH
HOH
2036
A
HOH
2037
6
HOH
HOH
2037
A
HOH
2038
6
HOH
HOH
2038
A
HOH
2039
6
HOH
HOH
2039
A
HOH
2040
6
HOH
HOH
2040
A
HOH
2041
6
HOH
HOH
2041
A
HOH
2042
6
HOH
HOH
2042
A
HOH
2043
6
HOH
HOH
2043
A
HOH
2044
6
HOH
HOH
2044
A
HOH
2045
6
HOH
HOH
2045
A
HOH
2046
6
HOH
HOH
2046
A
HOH
2047
6
HOH
HOH
2047
A
HOH
2048
6
HOH
HOH
2048
A
HOH
2049
6
HOH
HOH
2049
A
HOH
2050
6
HOH
HOH
2050
A
HOH
2051
6
HOH
HOH
2051
A
HOH
2052
6
HOH
HOH
2052
A
HOH
2053
6
HOH
HOH
2053
A
HOH
2054
6
HOH
HOH
2054
A
HOH
2055
6
HOH
HOH
2055
A
HOH
2056
6
HOH
HOH
2056
A
HOH
2057
6
HOH
HOH
2057
A
HOH
2058
6
HOH
HOH
2058
A
HOH
2059
6
HOH
HOH
2059
A
HOH
2060
6
HOH
HOH
2060
A
HOH
2061
6
HOH
HOH
2061
A
HOH
2062
6
HOH
HOH
2062
A
HOH
2063
6
HOH
HOH
2063
A
HOH
2064
6
HOH
HOH
2064
A
HOH
2065
6
HOH
HOH
2065
A
HOH
2066
6
HOH
HOH
2066
A
HOH
2067
6
HOH
HOH
2067
A
HOH
2068
6
HOH
HOH
2068
A
HOH
2069
6
HOH
HOH
2069
A
HOH
2070
6
HOH
HOH
2070
A
HOH
2071
6
HOH
HOH
2071
A
HOH
2072
6
HOH
HOH
2072
A
HOH
2073
6
HOH
HOH
2073
A
HOH
2074
6
HOH
HOH
2074
A
HOH
2075
6
HOH
HOH
2075
A
HOH
2076
6
HOH
HOH
2076
A
HOH
2077
6
HOH
HOH
2077
A
HOH
2078
6
HOH
HOH
2078
A
HOH
2079
6
HOH
HOH
2079
A
HOH
2080
6
HOH
HOH
2080
A
HOH
2081
6
HOH
HOH
2081
A
HOH
2082
6
HOH
HOH
2082
A
HOH
2083
6
HOH
HOH
2083
A
HOH
2084
6
HOH
HOH
2084
A
HOH
2085
6
HOH
HOH
2085
A
HOH
2086
6
HOH
HOH
2086
A
HOH
2087
6
HOH
HOH
2087
A
HOH
2088
6
HOH
HOH
2088
A
HOH
2089
6
HOH
HOH
2089
A
HOH
2090
6
HOH
HOH
2090
A
HOH
2091
6
HOH
HOH
2091
A
HOH
2092
6
HOH
HOH
2092
A
HOH
2093
6
HOH
HOH
2093
A
HOH
2094
6
HOH
HOH
2094
A
HOH
2095
6
HOH
HOH
2095
A
HOH
2096
6
HOH
HOH
2096
A
HOH
2097
6
HOH
HOH
2097
A
HOH
2098
6
HOH
HOH
2098
A
HOH
2099
6
HOH
HOH
2099
A
HOH
2100
6
HOH
HOH
2100
A
HOH
2101
6
HOH
HOH
2101
A
HOH
2102
6
HOH
HOH
2102
A
HOH
2103
6
HOH
HOH
2103
A
HOH
2104
6
HOH
HOH
2104
A
HOH
2105
6
HOH
HOH
2105
A
HOH
2106
6
HOH
HOH
2106
A
HOH
2107
6
HOH
HOH
2107
A
HOH
2108
6
HOH
HOH
2108
A
HOH
2109
6
HOH
HOH
2109
A
HOH
2110
6
HOH
HOH
2110
A
HOH
2111
6
HOH
HOH
2111
A
HOH
2112
6
HOH
HOH
2112
A
HOH
2113
6
HOH
HOH
2113
A
HOH
2114
6
HOH
HOH
2114
A
HOH
2115
6
HOH
HOH
2115
A
HOH
2116
6
HOH
HOH
2116
A
HOH
2117
6
HOH
HOH
2117
A
HOH
2118
6
HOH
HOH
2118
A
HOH
2119
6
HOH
HOH
2119
A
HOH
2120
6
HOH
HOH
2120
A
HOH
2121
6
HOH
HOH
2121
A
HOH
2122
6
HOH
HOH
2122
A
HOH
2123
6
HOH
HOH
2123
A
HOH
2124
6
HOH
HOH
2124
A
HOH
2125
6
HOH
HOH
2125
A
HOH
2126
6
HOH
HOH
2126
A
HOH
2127
6
HOH
HOH
2127
A
HOH
2128
6
HOH
HOH
2128
A
HOH
2129
6
HOH
HOH
2129
A
HOH
2130
6
HOH
HOH
2130
A
HOH
2131
6
HOH
HOH
2131
A
HOH
2132
6
HOH
HOH
2132
A
HOH
2133
6
HOH
HOH
2133
A
HOH
2134
6
HOH
HOH
2134
A
HOH
2135
6
HOH
HOH
2135
A
HOH
2136
6
HOH
HOH
2136
A
HOH
2137
6
HOH
HOH
2137
A
HOH
2138
6
HOH
HOH
2138
A
HOH
2139
6
HOH
HOH
2139
A
HOH
2140
6
HOH
HOH
2140
A
HOH
2141
6
HOH
HOH
2141
A
HOH
2142
6
HOH
HOH
2142
A
HOH
2143
6
HOH
HOH
2143
A
HOH
2144
6
HOH
HOH
2144
A
HOH
2145
6
HOH
HOH
2145
A
HOH
2146
6
HOH
HOH
2146
A
HOH
2147
6
HOH
HOH
2147
A
HOH
2148
6
HOH
HOH
2148
A
HOH
2149
6
HOH
HOH
2149
A
HOH
2150
6
HOH
HOH
2150
A
HOH
2151
6
HOH
HOH
2151
A
HOH
2152
6
HOH
HOH
2152
A
HOH
2153
6
HOH
HOH
2153
A
HOH
2154
6
HOH
HOH
2154
A
HOH
2155
6
HOH
HOH
2155
A
HOH
2156
6
HOH
HOH
2156
A
HOH
2157
6
HOH
HOH
2157
A
HOH
2158
6
HOH
HOH
2158
A
ILE
16
n
1
ILE
16
A
VAL
17
n
2
VAL
17
A
GLY
18
n
3
GLY
18
A
GLY
19
n
4
GLY
19
A
TYR
20
n
5
TYR
20
A
THR
21
n
6
THR
21
A
CYS
22
n
7
CYS
22
A
GLY
23
n
8
GLY
23
A
ALA
24
n
9
ALA
24
A
ASN
25
n
10
ASN
25
A
THR
26
n
11
THR
26
A
VAL
27
n
12
VAL
27
A
PRO
28
n
13
PRO
28
A
TYR
29
n
14
TYR
29
A
GLN
30
n
15
GLN
30
A
VAL
31
n
16
VAL
31
A
SER
32
n
17
SER
32
A
LEU
33
n
18
LEU
33
A
ASN
34
n
19
ASN
34
A
SER
37
n
20
SER
37
A
GLY
38
n
21
GLY
38
A
TYR
39
n
22
TYR
39
A
HIS
40
n
23
HIS
40
A
PHE
41
n
24
PHE
41
A
CYS
42
n
25
CYS
42
A
GLY
43
n
26
GLY
43
A
GLY
44
n
27
GLY
44
A
SER
45
n
28
SER
45
A
LEU
46
n
29
LEU
46
A
ILE
47
n
30
ILE
47
A
ASN
48
n
31
ASN
48
A
SER
49
n
32
SER
49
A
GLN
50
n
33
GLN
50
A
TRP
51
n
34
TRP
51
A
VAL
52
n
35
VAL
52
A
VAL
53
n
36
VAL
53
A
SER
54
n
37
SER
54
A
ALA
55
n
38
ALA
55
A
ALA
56
n
39
ALA
56
A
HIS
57
n
40
HIS
57
A
CYS
58
n
41
CYS
58
A
TYR
59
n
42
TYR
59
A
LYS
60
n
43
LYS
60
A
SER
61
n
44
SER
61
A
GLY
62
n
45
GLY
62
A
ILE
63
n
46
ILE
63
A
GLN
64
n
47
GLN
64
A
VAL
65
n
48
VAL
65
A
ARG
66
n
49
ARG
66
A
LEU
67
n
50
LEU
67
A
GLY
69
n
51
GLY
69
A
GLU
70
n
52
GLU
70
A
ASP
71
n
53
ASP
71
A
ASN
72
n
54
ASN
72
A
ILE
73
n
55
ILE
73
A
ASN
74
n
56
ASN
74
A
VAL
75
n
57
VAL
75
A
VAL
76
n
58
VAL
76
A
GLU
77
n
59
GLU
77
A
GLY
78
n
60
GLY
78
A
ASN
79
n
61
ASN
79
A
GLU
80
n
62
GLU
80
A
GLN
81
n
63
GLN
81
A
PHE
82
n
64
PHE
82
A
ILE
83
n
65
ILE
83
A
SER
84
n
66
SER
84
A
ALA
85
n
67
ALA
85
A
SER
86
n
68
SER
86
A
LYS
87
n
69
LYS
87
A
SER
88
n
70
SER
88
A
ILE
89
n
71
ILE
89
A
VAL
90
n
72
VAL
90
A
HIS
91
n
73
HIS
91
A
PRO
92
n
74
PRO
92
A
SER
93
n
75
SER
93
A
TYR
94
n
76
TYR
94
A
ASN
95
n
77
ASN
95
A
SER
96
n
78
SER
96
A
ASN
97
n
79
ASN
97
A
THR
98
n
80
THR
98
A
LEU
99
n
81
LEU
99
A
ASN
100
n
82
ASN
100
A
ASN
101
n
83
ASN
101
A
ASP
102
n
84
ASP
102
A
ILE
103
n
85
ILE
103
A
MET
104
n
86
MET
104
A
LEU
105
n
87
LEU
105
A
ILE
106
n
88
ILE
106
A
LYS
107
n
89
LYS
107
A
LEU
108
n
90
LEU
108
A
LYS
109
n
91
LYS
109
A
SER
110
n
92
SER
110
A
ALA
111
n
93
ALA
111
A
ALA
112
n
94
ALA
112
A
SER
113
n
95
SER
113
A
LEU
114
n
96
LEU
114
A
ASN
115
n
97
ASN
115
A
SER
116
n
98
SER
116
A
ARG
117
n
99
ARG
117
A
VAL
118
n
100
VAL
118
A
ALA
119
n
101
ALA
119
A
SER
120
n
102
SER
120
A
ILE
121
n
103
ILE
121
A
SER
122
n
104
SER
122
A
LEU
123
n
105
LEU
123
A
PRO
124
n
106
PRO
124
A
THR
125
n
107
THR
125
A
SER
127
n
108
SER
127
A
CYS
128
n
109
CYS
128
A
ALA
129
n
110
ALA
129
A
SER
130
n
111
SER
130
A
ALA
132
n
112
ALA
132
A
GLY
133
n
113
GLY
133
A
THR
134
n
114
THR
134
A
GLN
135
n
115
GLN
135
A
CYS
136
n
116
CYS
136
A
LEU
137
n
117
LEU
137
A
ILE
138
n
118
ILE
138
A
SER
139
n
119
SER
139
A
GLY
140
n
120
GLY
140
A
TRP
141
n
121
TRP
141
A
GLY
142
n
122
GLY
142
A
ASN
143
n
123
ASN
143
A
THR
144
n
124
THR
144
A
LYS
145
n
125
LYS
145
A
SER
146
n
126
SER
146
A
SER
147
n
127
SER
147
A
GLY
148
n
128
GLY
148
A
THR
149
n
129
THR
149
A
SER
150
n
130
SER
150
A
TYR
151
n
131
TYR
151
A
PRO
152
n
132
PRO
152
A
ASP
153
n
133
ASP
153
A
VAL
154
n
134
VAL
154
A
LEU
155
n
135
LEU
155
A
LYS
156
n
136
LYS
156
A
CYS
157
n
137
CYS
157
A
LEU
158
n
138
LEU
158
A
LYS
159
n
139
LYS
159
A
ALA
160
n
140
ALA
160
A
PRO
161
n
141
PRO
161
A
ILE
162
n
142
ILE
162
A
LEU
163
n
143
LEU
163
A
SER
164
n
144
SER
164
A
ASP
165
n
145
ASP
165
A
SER
166
n
146
SER
166
A
SER
167
n
147
SER
167
A
CYS
168
n
148
CYS
168
A
LYS
169
n
149
LYS
169
A
SER
170
n
150
SER
170
A
ALA
171
n
151
ALA
171
A
TYR
172
n
152
TYR
172
A
PRO
173
n
153
PRO
173
A
GLY
174
n
154
GLY
174
A
GLN
175
n
155
GLN
175
A
ILE
176
n
156
ILE
176
A
THR
177
n
157
THR
177
A
SER
178
n
158
SER
178
A
ASN
179
n
159
ASN
179
A
MET
180
n
160
MET
180
A
PHE
181
n
161
PHE
181
A
CYS
182
n
162
CYS
182
A
ALA
183
n
163
ALA
183
A
GLY
184
n
164
GLY
184
A
TYR
184
n
165
A
TYR
184
A
LEU
185
n
166
LEU
185
A
GLU
186
n
167
GLU
186
A
GLY
187
n
168
GLY
187
A
GLY
188
n
169
GLY
188
A
LYS
188
n
170
A
LYS
188
A
ASP
189
n
171
ASP
189
A
SER
190
n
172
SER
190
A
CYS
191
n
173
CYS
191
A
GLN
192
n
174
GLN
192
A
GLY
193
n
175
GLY
193
A
ASP
194
n
176
ASP
194
A
SER
195
n
177
SER
195
A
GLY
196
n
178
GLY
196
A
GLY
197
n
179
GLY
197
A
PRO
198
n
180
PRO
198
A
VAL
199
n
181
VAL
199
A
VAL
200
n
182
VAL
200
A
CYS
201
n
183
CYS
201
A
SER
202
n
184
SER
202
A
GLY
203
n
185
GLY
203
A
LYS
204
n
186
LYS
204
A
LEU
209
n
187
LEU
209
A
GLN
210
n
188
GLN
210
A
GLY
211
n
189
GLY
211
A
ILE
212
n
190
ILE
212
A
VAL
213
n
191
VAL
213
A
SER
214
n
192
SER
214
A
TRP
215
n
193
TRP
215
A
GLY
216
n
194
GLY
216
A
SER
217
n
195
SER
217
A
GLY
219
n
196
GLY
219
A
CYS
220
n
197
CYS
220
A
ALA
221
n
198
ALA
221
A
GLN
221
n
199
A
GLN
221
A
LYS
222
n
200
LYS
222
A
ASN
223
n
201
ASN
223
A
LYS
224
n
202
LYS
224
A
PRO
225
n
203
PRO
225
A
GLY
226
n
204
GLY
226
A
VAL
227
n
205
VAL
227
A
TYR
228
n
206
TYR
228
A
THR
229
n
207
THR
229
A
LYS
230
n
208
LYS
230
A
VAL
231
n
209
VAL
231
A
CYS
232
n
210
CYS
232
A
ASN
233
n
211
ASN
233
A
TYR
234
n
212
TYR
234
A
VAL
235
n
213
VAL
235
A
SER
236
n
214
SER
236
A
TRP
237
n
215
TRP
237
A
ILE
238
n
216
ILE
238
A
LYS
239
n
217
LYS
239
A
GLN
240
n
218
GLN
240
A
THR
241
n
219
THR
241
A
ILE
242
n
220
ILE
242
A
ALA
243
n
221
ALA
243
A
SER
244
n
222
SER
244
A
ASN
245
n
223
ASN
245
A
author_and_software_defined_assembly
PISA
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
TYR
20
A
N
TYR
5
A
O
CYS
157
A
O
CYS
137
A
N
ALA
160
A
N
ALA
140
A
O
CYS
136
A
O
CYS
116
A
N
SER
139
A
N
SER
119
A
O
PRO
198
A
O
PRO
180
A
N
CYS
201
A
N
CYS
183
A
O
LYS
204
A
O
LYS
186
A
N
SER
214
A
N
SER
192
A
O
VAL
227
A
O
VAL
205
A
N
TYR
228
A
N
TYR
206
A
O
PHE
181
A
O
PHE
161
A
O
LEU
33
A
O
LEU
18
A
N
PHE
41
A
N
PHE
24
A
N
ILE
47
A
N
ILE
30
A
O
TRP
51
A
O
TRP
34
A
N
SER
54
A
N
SER
37
A
O
MET
104
A
O
MET
86
A
O
LYS
107
A
O
LYS
89
A
N
SER
86
A
N
SER
68
A
N
ILE
83
A
N
ILE
65
A
O
VAL
65
A
O
VAL
48
A
N
ARG
66
A
N
ARG
49
A
O
SER
32
A
O
SER
17
1
A
HOH
2017
J
HOH
1
A
HOH
2101
J
HOH
1
A
A
O
N
THR
SER
125
127
0.93
1
A
A
O
O
HOH
HOH
2035
2038
1.48
1
A
A
O
O
HOH
HOH
2120
2123
1.95
1
A
A
ND2
O1
ASN
EDO
74
1249
2.01
1
A
A
NE2
O
GLN
HOH
240
2156
2.10
1
A
A
O
O
HOH
HOH
2046
2067
2.14
1
A
A
NZ
O
LYS
HOH
169
2125
2.17
B
1
A
THR
125
103.05
1
A
SER
217
12.63
A
1
A
A
C
N
THR
SER
125
127
1.07
A
1
A
A
C
N
GLY
LYS
188
188
1.77
B
A
1
A
A
C
N
GLY
LYS
188
188
1.84
A
1
33.41
2.20
117.20
150.61
A
A
A
CA
C
N
THR
THR
SER
125
125
127
Y
1
-77.33
1.60
122.70
45.37
A
A
A
O
C
N
THR
THR
SER
125
125
127
Y
1
24.81
2.50
121.70
146.51
A
A
A
C
N
CA
THR
SER
SER
125
127
127
Y
1
5.72
0.90
118.30
124.02
A
A
A
CB
CG
OD1
ASP
ASP
ASP
153
153
153
B
B
B
N
1
A
A
C
N
THR
SER
125
127
-0.269
0.023
1.336
1.067
Y
1
A
A
C
N
SER
GLY
217
219
0.176
0.023
1.336
1.512
A
Y
1
A
A
C
N
SER
GLY
217
219
0.238
0.023
1.336
1.574
B
Y
A
1
A
A
C
N
ALA
GLN
221
221
0.157
0.023
1.336
1.493
Y
1
A
A
OH
OD2
TYR
ASP
59
153
1.68
B
1_555
4_455
1
A
ASP
71
-116.91
-73.28
16.709
-0.34
-0.17
0.00
-0.34
0.00
0.51
0.961
0.947
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. HYDROGENS HAVE BEEN USED IF PRESENT IN THE INPUT. U VALUES REFINED INDIVIDUALLY.
0.20470
0.16878
0.17059
1.60
47.05
1242
23176
5.1
99.97
1.636
0.059
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.100
0.098
0.80
0.80
1.20
PDB ENTRY 1K1M
MAXIMUM LIKELIHOOD
MASK
1.60
47.05
158
1826
39
0
1629
0.022
0.019
1879
2.253
1.970
2542
6.502
5.000
249
38.851
26.066
61
14.173
15.000
311
17.195
15.000
2
0.162
0.200
280
0.014
0.021
1405
0.307
0.233
1.642
82
1510
20
99.87
1.60
52.70
4AB8
24461
1.0
0.07
1
22.60
10.0
99.9
0.66
1.60
1.69
3.40
1
8.7
99.9
refinement
REFMAC
5.6.0117
data reduction
XDS
data scaling
SCALA
phasing
PHASER
Fragments bound to bovine trypsin for the SAMPL challenge
1
N
N
2
N
N
3
N
N
4
N
N
4
N
N
4
N
N
4
N
N
4
N
N
5
N
N
6
N
N
A
ALA
55
A
ALA
38
HELX_P
A
TYR
59
A
TYR
42
5
1
5
A
SER
164
A
SER
144
HELX_P
A
TYR
172
A
TYR
152
1
2
9
A
TYR
234
A
TYR
212
HELX_P
A
SER
244
A
SER
222
1
3
11
disulf
2.073
A
CYS
22
A
SG
CYS
7
1_555
A
CYS
157
A
SG
CYS
137
1_555
disulf
2.023
A
CYS
42
A
SG
CYS
25
1_555
A
CYS
58
A
SG
CYS
41
1_555
disulf
2.046
A
CYS
128
A
SG
CYS
109
1_555
A
CYS
232
A
SG
CYS
210
1_555
disulf
1.994
A
CYS
136
A
SG
CYS
116
1_555
A
CYS
201
A
SG
CYS
183
1_555
disulf
2.039
A
CYS
168
A
SG
CYS
148
1_555
A
CYS
182
A
SG
CYS
162
1_555
disulf
2.027
A
CYS
191
A
SG
CYS
173
1_555
A
CYS
220
A
SG
CYS
197
1_555
HYDROLASE
HYDROLASE, FRAGMENT SCREENING, MODELLING
TRY1_BOVIN
UNP
1
P00760
24
246
4AB8
16
245
P00760
A
1
1
223
7
7
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
TYR
20
A
TYR
5
A
THR
21
A
THR
6
A
LYS
156
A
LYS
136
A
PRO
161
A
PRO
141
A
GLN
135
A
GLN
115
A
GLY
140
A
GLY
120
A
PRO
198
A
PRO
180
A
CYS
201
A
CYS
183
A
LYS
204
A
LYS
186
A
TRP
215
A
TRP
193
A
GLY
226
A
GLY
204
A
LYS
230
A
LYS
208
A
MET
180
A
MET
160
A
ALA
183
A
ALA
163
A
GLN
30
A
GLN
15
A
ASN
34
A
ASN
19
A
HIS
40
A
HIS
23
A
ASN
48
A
ASN
31
A
TRP
51
A
TRP
34
A
SER
54
A
SER
37
A
MET
104
A
MET
86
A
LEU
108
A
LEU
90
A
GLN
81
A
GLN
63
A
VAL
90
A
VAL
72
A
GLN
64
A
GLN
47
A
LEU
67
A
LEU
50
A
GLN
30
A
GLN
15
A
ASN
34
A
ASN
19
BINDING SITE FOR RESIDUE SO4 A 1246
A
SO4
1246
Software
6
BINDING SITE FOR RESIDUE CA A 1247
A
CA
1247
Software
6
BINDING SITE FOR RESIDUE EDO A 1248
A
EDO
1248
Software
8
BINDING SITE FOR RESIDUE EDO A 1249
A
EDO
1249
Software
8
BINDING SITE FOR RESIDUE EDO A 1250
A
EDO
1250
Software
4
BINDING SITE FOR RESIDUE EDO A 1251
A
EDO
1251
Software
4
BINDING SITE FOR RESIDUE EDO A 1252
A
EDO
1252
Software
6
BINDING SITE FOR RESIDUE VXU A 1253
A
VXU
1253
Software
14
A
HIS
57
A
HIS
40
6
1_555
A
GLN
192
A
GLN
174
6
1_555
A
GLY
193
A
GLY
175
6
1_555
A
SER
195
A
SER
177
6
1_555
A
VXU
1253
I
VXU
6
1_555
A
HOH
2043
J
HOH
6
1_555
A
GLU
70
A
GLU
52
6
1_555
A
ASN
72
A
ASN
54
6
1_555
A
VAL
75
A
VAL
57
6
1_555
A
GLU
80
A
GLU
62
6
1_555
A
HOH
2052
J
HOH
6
1_555
A
HOH
2053
J
HOH
6
1_555
A
ARG
66
A
ARG
49
8
1_555
A
ILE
73
A
ILE
55
8
1_555
A
VAL
76
A
VAL
58
8
1_555
A
VAL
90
A
VAL
72
8
4_565
A
HIS
91
A
HIS
73
8
4_565
A
PRO
92
A
PRO
74
8
4_565
A
HOH
2052
J
HOH
8
1_555
A
HOH
2073
J
HOH
8
4_565
A
TYR
39
A
TYR
22
8
1_555
A
HIS
40
A
HIS
23
8
1_555
A
ILE
73
A
ILE
55
8
1_555
A
ASN
74
A
ASN
56
8
1_555
A
ILE
89
A
ILE
71
8
4_565
A
VAL
90
A
VAL
72
8
4_565
A
HOH
2026
J
HOH
8
1_555
A
HOH
2070
J
HOH
8
4_565
A
ASN
100
A
ASN
82
4
1_555
A
SER
110
A
SER
92
4
2_455
A
HOH
2076
J
HOH
4
1_555
A
HOH
2158
J
HOH
4
1_555
A
VAL
76
A
VAL
58
4
1_555
A
PHE
82
A
PHE
64
4
1_555
A
HOH
2059
J
HOH
4
1_555
A
HOH
2065
J
HOH
4
1_555
A
CYS
128
A
CYS
109
6
1_555
A
ALA
129
A
ALA
110
6
1_555
A
PHE
181
A
PHE
161
6
1_555
A
GLN
210
A
GLN
188
6
1_555
A
CYS
232
A
CYS
210
6
1_555
A
HOH
2145
J
HOH
6
1_555
A
ASP
189
A
ASP
171
14
1_555
A
SER
190
A
SER
172
14
1_555
A
CYS
191
A
CYS
173
14
1_555
A
GLN
192
A
GLN
174
14
1_555
A
SER
195
A
SER
177
14
1_555
A
VAL
213
A
VAL
191
14
1_555
A
TRP
215
A
TRP
193
14
1_555
A
GLY
216
A
GLY
194
14
1_555
A
GLY
219
A
GLY
196
14
1_555
A
CYS
220
A
CYS
197
14
1_555
A
GLY
226
A
GLY
204
14
1_555
A
SO4
1246
B
SO4
14
1_555
A
HOH
2130
J
HOH
14
1_555
A
HOH
2142
J
HOH
14
1_555
152
P 31 2 1